FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and consists in clathrate complexes of arabinogalactan or arabic gum with 20-hydroxyecdysone. The complexes possesses antidiabetic activity and hypolipidemic action. The invention also refers to a liquid-phase and solid-phase method for producing the clathrate complexes, to a pharmaceutical composition and a based medicinal product.
EFFECT: presented clathrate complexes enables increasing water solubility of medicinal products, improving bioavailability, reducing dosages of the medicinal products and toxicity of 20-hydroxyecdysone.
23 cl, 1 ex, 2 tbl, 8 dwg
Title | Year | Author | Number |
---|---|---|---|
USE OF CLATHRATE COMPLEX OF 20-HYDROXYECDYSONE WITH ARABINOGALACTAN FOR NORMALIZATION OF METABOLISM, INCREASE IN NON-SPECIFIC RESISTANCE, GROWTH AND DEVELOPMENT OF ANIMALS | 2019 |
|
RU2776671C2 |
CLATRATE COMPLEX OF CYCLODEXTRINE OR ARABINOGALACTANE WITH 9-PHENYL-SYMM-OCTAHYDROSELENOXANTENE, ITS PRODUCTION METHOD (VERSIONS), PHARMACEUTICAL COMPOSITION AND MEDICATION | 2011 |
|
RU2451680C1 |
SUPRAMOLECULAR COMPLEX, POSSESSING ANTI-INFLAMMATORY AND ANGIOPROTECTIVE ACTIVITY AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2533231C1 |
WATER-SOLUBLE MEDICINAL COMPOSITION AND METHOD OF PRODUCTION THEREOF | 2006 |
|
RU2337710C2 |
ALBENDAZOLE-BASED COMPOSITION WITH ANTI-OPISTHORCHOSIS PHARMACOLOGICAL ACTIVITY | 2013 |
|
RU2545797C1 |
GYNOSTEMMA PENTAPHYLLUM COMPOSITION WITH HIGH PHARMACOLOGICAL ACTIVITY | 2013 |
|
RU2568883C2 |
DIPROPIONATE BETULIN COMPOSITION | 2013 |
|
RU2541153C1 |
BETULIN DIACETATE-BASED COMPOSITION | 2013 |
|
RU2517157C1 |
AGENT POSSESSING LYMPHOKINETIC ACTIVITY | 2014 |
|
RU2560518C1 |
USE OF RHODANINE DERIVATIVE 3-(2-PHENYLETHYL)-2-THIOXO-1,3 THIAZOLIDIN-4-ONE FOR CORRECTION OF METABOLIC DISORDERS | 2019 |
|
RU2768171C2 |
Authors
Dates
2016-01-10—Published
2013-12-06—Filed